All Stories

  1. EatA mediated degradation of intestinal mucus is species-specific and driven by MUC2 structural features
  2. ETEC heat-labile toxin promotes β-catenin stabilization and transcriptional reprogramming to disrupt intestinal epithelial differentiation
  3. Parenteral vaccination with recombinant EtpA glycoprotein impairs enterotoxigenic E. coli colonization
  4. Degradation of the intestinal mucus layer by the ETEC protease EatA is species specific determined by the structure of the MUC2 mucin
  5. Parenteral Vaccination with recombinant EtpA glycoprotein impairs enterotoxigenic E. coli colonization
  6. Repeat modules and N-linked glycans define structure and antigenicity of a critical enterotoxigenic E. coli adhesin
  7. Host-derived CEACAM-laden vesicles engage enterotoxigenic Escherichia coli for elimination and toxin neutralization
  8. Structural and biophysical characterization of the secreted, β-helical adhesin EtpA of Enterotoxigenic Escherichia coli
  9. Interactions of pathogenic Escherichia coli with CEACAMs
  10. Spontaneous Bacterial Peritonitis Caused by Bordetella hinzii
  11. Confronting Challenges to Enterotoxigenic Escherichia coli Vaccine Development
  12. Changing the locks on intestinal signaling
  13. Effect of chronic alcohol exposure on gut vitamin B7 uptake: involvement of epigenetic mechanisms and effect of alcohol metabolites
  14. Emerging Themes in the Molecular Pathogenesis of Enterotoxigenic Escherichia coli
  15. Vaccines for Protecting Infants from Bacterial Causes of Diarrheal Disease
  16. Acute Bacterial Gastroenteritis
  17. Contribution of Noncanonical Antigens to Virulence and Adaptive Immunity in Human Infection with Enterotoxigenic E. coli
  18. The Intriguing Interaction of Escherichia coli with the Host Environment and Innovative Strategies To Interfere with Colonization: a Summary of the 2019 E. coli and the Mucosal Immune System Meeting
  19. CEACAMs serve as toxin-stimulated receptors for enterotoxigenic Escherichia coli
  20. Phosphodiesterase 5 (PDE5) restricts intracellular cGMP accumulation during enterotoxigenic Escherichia coli infection
  21. Mechanical Stimuli Affect Escherichia coli Heat-Stable Enterotoxin-Cyclic GMP Signaling in a Human Enteroid Intestine-Chip Model
  22. Comparative genomic analysis and molecular examination of the diversity of enterotoxigenic Escherichia coli isolates from Chile
  23. Mechanical Stimuli Affect E. Coli Heat Stable Enterotoxin (ST)-Cyclic GMP Signaling in a Human Enteroid Intestine-Chip Diarrhea Model
  24. Interrogation of a live-attenuated enterotoxigenic Escherichia coli vaccine highlights features unique to wild-type infection
  25. How genomics can be used to understand host susceptibility to enteric infection, aiding in the development of vaccines and immunotherapeutic interventions
  26. Enterotoxigenic Escherichia coli–blood group A interactions intensify diarrheal severity
  27. Enterotoxigenic Escherichia coli Infections
  28. Molecular Determinants of Enterotoxigenic Escherichia coli Heat-Stable Toxin Secretion and Delivery
  29. Enterotoxigenic Escherichia coli–blood group A interactions intensify diarrheal severity
  30. Human Experimental Challenge With Enterotoxigenic Escherichia coli Elicits Immune Responses to Canonical and Novel Antigens Relevant to Vaccine Development
  31. Molecular determinants of enterotoxigenic Escherichia coli heat-stable toxin secretion and delivery
  32. A Role for Salivary Peptides in the Innate Defense Against Enterotoxigenic Escherichia coli
  33. Characterization of enterotoxigenic Escherichia coli strains isolated from the massive multi-pathogen gastroenteritis outbreak in the Antofagasta region following the Chilean earthquake, 2010
  34. Comparative genomics and transcriptomics of Escherichia coli isolates carrying virulence factors of both enteropathogenic and enterotoxigenic E. coli
  35. Insights into enterotoxigenic Escherichia coli diversity in Bangladesh utilizing genomic epidemiology
  36. Providing Structure to Enterotoxigenic Escherichia coli Vaccine Development
  37. Highly conserved type 1 pili promote enterotoxigenic E. coli pathogen-host interactions
  38. Dynamic Interactions of a Conserved Enterotoxigenic Escherichia coli Adhesin with Intestinal Mucins Govern Epithelium Engagement and Toxin Delivery
  39. Blood Group O–Dependent Cellular Responses to Cholera Toxin: Parallel Clinical and Epidemiological Links to Severe Cholera
  40. Immunogenicity and Protective Efficacy against Enterotoxigenic Escherichia coli Colonization following Intradermal, Sublingual, or Oral Vaccination with EtpA Adhesin
  41. Overcoming Enterotoxigenic Escherichia coli Pathogen Diversity: Translational Molecular Approaches to Inform Vaccine Design
  42. Examination of the Enterotoxigenic Escherichia coli Population Structure during Human Infection
  43. Conservation and Immunogenicity of Novel Antigens in Diverse Isolates of Enterotoxigenic Escherichia coli
  44. Contribution of the Highly Conserved EaeH Surface Protein to Enterotoxigenic Escherichia coli Pathogenesis
  45. Designing Vaccines to Neutralize Effective Toxin Delivery by Enterotoxigenic Escherichia coli
  46. Novel antigens for enterotoxigenicEscherichia colivaccines
  47. Enterotoxigenic Escherichia coli Secretes a Highly Conserved Mucin-Degrading Metalloprotease To Effectively Engage Intestinal Epithelial Cells
  48. EatA, an Immunogenic Protective Antigen of Enterotoxigenic Escherichia coli, Degrades Intestinal Mucin
  49. EnterotoxigenicEscherichia coli
  50. Escherichia coli Sequence Type 131 (ST131) Subclone H30 as an Emergent Multidrug-Resistant Pathogen Among US Veterans
  51. Enterotoxigenic Escherichia coli
  52. Transcriptional Modulation of Enterotoxigenic Escherichia coli Virulence Genes in Response to Epithelial Cell Interactions
  53. Cooperative Role of Antibodies against Heat-Labile Toxin and the EtpA Adhesin in Preventing Toxin Delivery and Intestinal Colonization by Enterotoxigenic Escherichia coli
  54. Directed Evaluation of Enterotoxigenic Escherichia coli Autotransporter Proteins as Putative Vaccine Candidates
  55. Outer Membrane Vesicles Induce Immune Responses to Virulence Proteins and Protect against Colonization by Enterotoxigenic Escherichia coli
  56. Adhesin Degradation Accelerates Delivery of Heat-labile Toxin by EnterotoxigenicEscherichia coli
  57. Infectious Agents of Food- and Water-Borne Illnesses
  58. Enterotoxigenic Escherichia coli Elicits Immune Responses to Multiple Surface Proteins
  59. Lingual Leishmaniasis Complicating Visceral Disease
  60. Molecular mechanisms of enterotoxigenic Escherichia coli infection
  61. Vaccination with EtpA glycoprotein or flagellin protects against colonization with enterotoxigenic Escherichia coli in a murine model
  62. Purification of recombinant high molecular weight two-partner secretion proteins from Escherichia coli
  63. Enterotoxigenic Escherichia coli EtpA mediates adhesion between flagella and host cells
  64. Heat-Labile Enterotoxin Promotes Escherichia coli Adherence to Intestinal Epithelial Cells
  65. The EtpA Exoprotein of Enterotoxigenic Escherichia coli Promotes Intestinal Colonization and Is a Protective Antigen in an Experimental Model of Murine Infection
  66. Directed delivery of heat-labile enterotoxin by enterotoxigenic Escherichia coli
  67. Identification of a Two-Partner Secretion Locus of Enterotoxigenic Escherichia coli
  68. Importance of Heat-Labile Enterotoxin in Colonization of the Adult Mouse Small Intestine by Human Enterotoxigenic Escherichia coli Strains
  69. Identification and Molecular Characterization of EatA, an Autotransporter Protein of Enterotoxigenic Escherichia coli
  70. Interaction of an Outer Membrane Protein of Enterotoxigenic Escherichia coli with Cell Surface Heparan Sulfate Proteoglycans
  71. Breaching the mucosal barrier by stealth: an emerging pathogenic mechanism for enteroadherent bacterial pathogens
  72. Identification of a Gene within a Pathogenicity Island of Enterotoxigenic Escherichia coli H10407 Required for Maximal Secretion of the Heat-Labile Enterotoxin
  73. Incidental Discovery of Emphysematous Cystitis
  74. Cryptococcal Skull Infection